Desoximetasone Cream USP — Class II drug recall D-0117-2017
Terminated recall by Taro Pharmaceuticals, Inc., reported 2016-11-09, distributed in PR. Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separat
| Recall number | D-0117-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Taro Pharmaceuticals, Inc., Brampton, Canada |
| Recall initiated | 2016-09-13 |
| Classified | 2016-11-01 |
| Reported by FDA | 2016-11-09 |
| Terminated | 2018-06-15 |
| Distributed | PR |
| Quantity | 6,756 units |
| Reason classes | specification failure |
| NDC | 51672-1261, 51672-1261-01, 51672-1261-02, 51672-1261-03, 51672-1270, 51672-1270-01, 51672-1270-02, 51672-1270-03, 51672-1270-07, 51672-1271, 51672-1271-01, 51672-1271-02, 51672-1271-03, 51672-1271-07 |
| Lot numbers | E0598-19624, E5099-19624 |
| Expiration dates | 2017-01-20 |
Product
Desoximetasone Cream USP, 0.05% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532; NDC 51672-1271-7
Reason for recall
Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0117-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.